Ad is loading...
HGXTX
Price
$15.47
Change
-$0.15 (-0.96%)
Updated
Nov 15 closing price
RSLEX
Price
$68.12
Change
-$0.84 (-1.22%)
Updated
Nov 15 closing price
Ad is loading...

HGXTX vs RSLEX

Header iconHGXTX vs RSLEX Comparison
Open Charts HGXTX vs RSLEXBanner chart's image
Hartford Global Impact R5
Price$15.47
Change-$0.15 (-0.96%)
VolumeN/A
CapitalizationN/A
American Funds SMALLCAP World R4
Price$68.12
Change-$0.84 (-1.22%)
VolumeN/A
CapitalizationN/A
HGXTX vs RSLEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HGXTX vs. RSLEX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HGXTX is a StrongBuy and RSLEX is a Buy.

FUNDAMENTALS
Fundamentals
RSLEX has more cash in the bank: 74.7B vs. HGXTX (240M). HGXTX pays higher dividends than RSLEX: HGXTX (1.03) vs RSLEX (0.65). HGXTX was incepted earlier than RSLEX: HGXTX (8 years) vs RSLEX (22 years). HGXTX is a more actively managed with annual turnover of: 34.00 vs. RSLEX (29.00). HGXTX has a lower initial minimum investment than RSLEX: HGXTX (0) vs RSLEX (250). HGXTX annual gain was more profitable for investors over the last year : 20.46 vs. RSLEX (16.00). HGXTX return over 5 years is better than : 41.10 vs. RSLEX (18.89).
HGXTXRSLEXHGXTX / RSLEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years22 years-
Gain YTD9.4063.747251%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets240M74.7B0%
Annual Yield % from dividends1.030.65157%
Returns for 1 year20.4616.00128%
Returns for 3 years-9.47-25.8637%
Returns for 5 years41.1018.89218%
Returns for 10 yearsN/A39.00-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACVA20.720.70
+3.50%
ACV Auctions
FBMS36.370.12
+0.33%
First Bancshares
HFFG3.42-0.04
-1.16%
HF Foods Group
UTHR363.25-23.02
-5.96%
United Therapeutics Corp
NLSP3.13-0.21
-6.29%
Nls Pharmaceutics Ltd